Zolgensma launch 'on track and fully in line' with expectation, says Novartis CEO | Fierce Pharma
Zolgensma SMA therapy confirms long-term efficacy for up to 7.5 years < Pharma < Article - KBR
Novartis Reveals Two Deaths Related to SMA Drug Zolgensma | BioSpace
Novartis Lauds Quebec's Move to Reimburse SMA Patients for Zolgensma
Novartis releases long-term Zolgensma data
Health Canada approves Zolgensma®, the one-time gene therapy for pediatric patients with spinal muscular atrophy (SMA)
Health Canada approves Zolgensma®, the one-time gene therapy for pediatric patients with spinal muscular atrophy (SMA)
FDA Accepts AveXis' BLA for SMA Drug Zolgensma Under Priority Review - Muscular Dystrophy Association
$2.1m Novartis gene therapy to become world's most expensive drug | Drugs | The Guardian
Novartis expands Zolgensma manufacturing capacity with approval of multi-product North Carolina facility
R&D report card: Zolgensma-maker Novartis' spending reaches $9.4B in 2019 | S&P Global Market Intelligence
Novartis' 'full-court press' key to ensuring rapid Zolgensma access
Novartis allies with Voyager to develop gene therapies in $1.3bn deal
Test Achats porte plainte contre un médicament à 2 millions d'euros
Novartis says it knew of Zolgensma data problems before U.S. approval - The Japan Times
Novartis slaps $2M-plus price tag on newly approved gene therapy Zolgensma—and cost watchdogs approve | Fierce Pharma
Zolgensma® data including patients with more severe SMA at baseline further demonstrate therapeutic benefit, including prolonge
Path clears for Novartis's Zolgensma after FDA lifts longstanding hold
Zolgensma® data shows rapid, significant, clinically meaningful benefit in SMA including prolonged event- free survival, motor
Novartis Boosts Zolgensma Production Capacity After FDA Clearance
Zolgensma gene therapy for sma patients: long-term data
R&D report card: Zolgensma-maker Novartis' spending reaches $9.4B in 2019 | S&P Global Market Intelligence
Novartis's SMA gene therapy Zolgensma to be available for NHS use - Pharmaceutical Technology
